Key result
Individualized decisions about preoperative anticoagulant suspension, bridging therapy, and restart times can significantly reduce bleeding and thromboembolic risks in atrial fibrillation patients undergoing surgery.
Why the study?
How should oral anticoagulants be managed perioperatively to minimize bleeding and thromboembolic complications in patients with atrial fibrillation undergoing surgery?
How should oral anticoagulants be managed perioperatively to minimize bleeding and thromboembolic complications in patients with atrial fibrillation undergoing surgery?
Individualized, protocol-driven perioperative management of anticoagulation in AF patients is essential to balance the risks of bleeding and thromboembolism.
No takes yet. Share an insight, caveat, or question.
Supports individualized perioperative OAC management in AF; leaves open optimal protocols pending prospective validation.
Charles André (2015) conducted a review in Atrial fibrillation in patients undergoing surgery. Perioperative anticoagulant management was evaluated. Individualized decisions about preoperative anticoagulant suspension, bridging therapy, and restart times can significantly reduce bleeding and thromboembolic risks in atrial fibrillation patients undergoing surgery.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: